- Report
- January 2024
- 175 Pages
Global
From €4804EUR$5,000USD£4,107GBP
- Report
- January 2024
- 200 Pages
Global
From €4804EUR$5,000USD£4,107GBP
- Report
- February 2018
- 5 Pages
Global
Mucinex is a brand of over-the-counter (OTC) medications used to treat respiratory illnesses such as the common cold, bronchitis, and sinusitis. It is a combination of guaifenesin and dextromethorphan, two active ingredients that help to reduce mucus production and suppress coughing. Mucinex is available in a variety of forms, including tablets, capsules, and liquid suspensions.
Mucinex is part of the larger respiratory drug market, which includes medications used to treat a range of respiratory illnesses, from the common cold to more serious conditions such as asthma and COPD. These drugs are available in both OTC and prescription forms, and are used to reduce symptoms such as coughing, wheezing, and difficulty breathing.
Some of the companies in the Mucinex market include Reckitt Benckiser, which manufactures the Mucinex brand, as well as other OTC respiratory medications such as Delsym and Mucinex DM. Other companies in the market include GlaxoSmithKline, which produces Flonase and Advair, and Boehringer Ingelheim, which manufactures Spiriva and Combivent. Show Less Read more